Your browser doesn't support javascript.
loading
The potassium channel Kcne3 is a VEGFA-inducible gene selectively expressed by vascular endothelial tip cells.
Deckelbaum, Ron A; Lobov, Ivan B; Cheung, Eunice; Halasz, Gabor; Rajamani, Saathyaki; Lerner, Julia; Tong, Chunxiang; Li, Zhe; Boland, Patricia; Dominguez, Melissa; Hughes, Virginia; Yancopoulos, George D; Murphy, Andrew J; Thurston, Gavin; Cao, Jingtai; Romano, Carmelo; Gale, Nicholas W.
Affiliation
  • Deckelbaum RA; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA. ron.deckelbaum@regeneron.com.
  • Lobov IB; Palmira Biopharma, Moscow, 143026, RF, Russia.
  • Cheung E; Department of Ophthalmology, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Halasz G; Department of Bioinformatics, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Rajamani S; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Lerner J; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Tong C; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Li Z; Department of Oncology & Angiogenesis, Regeneron Pharmaceuticals Inc., Tarrytown, NY, 10591, USA.
  • Boland P; Department of Oncology & Angiogenesis, Regeneron Pharmaceuticals Inc., Tarrytown, NY, 10591, USA.
  • Dominguez M; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Hughes V; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Yancopoulos GD; Department of Research, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Murphy AJ; Department of Research, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Thurston G; Department of Oncology & Angiogenesis, Regeneron Pharmaceuticals Inc., Tarrytown, NY, 10591, USA.
  • Cao J; Department of Ophthalmology, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Romano C; Department of Ophthalmology, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
  • Gale NW; Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
Angiogenesis ; 23(2): 179-192, 2020 05.
Article in En | MEDLINE | ID: mdl-31754927

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neovascularization, Physiologic / Potassium Channels, Voltage-Gated / Endothelial Cells / Vascular Endothelial Growth Factor A / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals / Pregnancy Language: En Journal: Angiogenesis Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neovascularization, Physiologic / Potassium Channels, Voltage-Gated / Endothelial Cells / Vascular Endothelial Growth Factor A / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals / Pregnancy Language: En Journal: Angiogenesis Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: United States